Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sinuvowen is a homeopathic complex preparation developed by Weber & Weber Biologische Arzneimittel for the treatment of acute and chronic sinusitis. It is formulated as oral drops containing a combination of six active ingredients: *Ammi visnaga*, *Cinnabaris* (Hydrargyrum sulfuratum rubrum), *Echinacea*, *Euphorbium*, *Kalium bichromicum*, and *Luffa operculata*. The preparation is designed to address inflammation of the paranasal sinuses by promoting the liquefaction and drainage of mucus, reducing mucosal swelling, and supporting the immune system. As a homeopathic medicine, it functions according to the principle of similia similibus curentur (like cures like), aiming to stimulate the body's self-regulatory and healing capacities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sinuvowen.